Latest Paxman News & Updates

See the latest news and media coverage for Paxman. We track all announcements, press releases, and industry mentions in real time, all in one place.

Paxman

World leader in scalp cooling technology

Latest news about Paxman

April 30 Paxman

Paxman reports growing momentum for scalp cooling insurance bills

West Virginia and Maryland passed bills effective January 2027. Advocates shared experiences on House and Senate floors.
April 29 Paxman

Paxman shares key points from Scalp Cooling Registry

The largest study examines 7,424 patients in real-world settings. Data supports the Paxman Scalp Cooling Outcomes Calculator for clinicians.
April 24 Paxman

Paxman publishes 2025 Annual Report

The report highlights US reimbursement progress, Dignitana acquisition, and innovation in scalp cooling and neuropathy programs. CEO calls it the biggest year yet.
April 24 Paxman

Paxman publishes the annual report for 2025

The annual report in Swedish and a shortened English version are available on the website. Printed copy can be ordered via e-mail to CFO.

March 16 MSN

'I am incredibly honoured' - Brighouse health innovation wins £100,000 to expand across hospitals

A Calderdale health innovation helping patients manage anxiety during high-stress medical treatments such as chemotherapy has won £100,000 in the Mayor's Big Ideas Challenge.
March 12 MarketWatch

Paxman: Momentum Accelerates as 11 States Pursue Scalp Cooling Coverage Legislation in the U.S.

The MarketWatch News Department was not involved in the creation of this content. HOUSTON, March 12, 2026 /PRNewswire/ -- Building on statewide insurance mandates enacted...
February 27 FinanzNachrichten

Paxman AB: PAXMAN publishes year-end report as of 31 December 2025

Strategic investments support future growth! Figures in parentheses refer to the outcome for the corresponding period of the previous year.The Group's net sales amounted to...
February 20 FinanzNachrichten

Paxman AB: Paxman Announces Category III CPT Codes for Cryocompression Therapy to Prevent Chemotherapy-Induced Peripheral Neuropathy

Paxman, the global leader in cancer side effect management, today announced that the American Medical Association (AMA) CPT Editorial Panel has established three Category III...

Never miss news about Paxman

Track Paxman and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Browse news for competitors to Paxman and other trending companies.